Phathom Pharmaceuticals, Inc. - Common Stock (PHAT)

CUSIP: 71722W107

Q4 2022 13F Holders as of 31 Dec 2022

Holder snapshot 7 signals
Share change
-1,971,377
Put/Call ratio
142%
SEC-reported price per share
$11.22
Number of holders
83
Value change
-$21,719,929
Number of buys
40
Open additional details 1 more signal available
Number of sells
37
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
79,611,764

Security key

71722W107

Report period

Q4 2022

Institutions

83

Top holders

10

Ownership snapshot

Top reported holders of PHAT - Phathom Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Frazier Life Sciences Man...
Disclosed value leader
Frazier Life Sciences Man...
Comparable rows
0/15
Latest evidence
30 Sep 2022
13F Highest disclosed value: $93,151,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Frazier Life Sciences Management, L.P. has the largest disclosed position value at $93.15M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Frazier Life Sciences Management, L.P.'s linked filing trail.
Disclosed position value Top 5
Frazier Life Sciences Management,... $93.15M
Medicxi Ventures Management (Jers... $27.53M
DEERFIELD MANAGEMENT COMPANY, L.P. $26.76M
Invesco Ltd. $22.91M
Avidity Partners Management LP $21.13M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Frazier Life Sciences Management, L.P.
13F
Company
13F
—
denominator unverified
$93,151,000
8,407,152 shares
— 30 Sep 2022
Medicxi Ventures Management (Jersey) Ltd
13F
Company
13F
—
denominator unverified
$27,526,000
2,484,274 shares
— 30 Sep 2022
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
13F
—
denominator unverified
$26,757,000
2,414,897 shares
— 30 Sep 2022
Invesco Ltd.
13F
Company
13F
—
denominator unverified
$22,912,000
2,067,868 shares
— 30 Sep 2022
Avidity Partners Management LP
13F
Company
13F
—
denominator unverified
$21,127,000
1,906,800 shares
— 30 Sep 2022
Ensign Peak Advisors, Inc
13F
Company
13F
—
denominator unverified
$19,514,000
1,761,191 shares
— 30 Sep 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
83
Shares
28,212,747
Rows available
83
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders
87
Q4 2022 holders
83
Holder diff
-4
Investor Q3 2022 Shares Q4 2022 Shares Share Diff Share Chg % Q3 2022 value Q4 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .